SEC Form 4 · accession 0001209191-18-034195
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey M. Parker
Director
Period of report
May 25, 2018
Accepted (ET)
May 30, 2018 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2018 | M | 12,912 | $0.00 | A | 58,583 | D | |
| Common Stock | holding | — | — | — | 99,600 | I | Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust | |
| Common Stock | holding | — | — | — | 5,000 | I | By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | May 25, 2018 | M | 12,912 | D | — | — | Common Stock | 12,912 | 0 | D |
Explanation of responses
- F1Shares were acquired upon vesting of restricted stock units awarded on May 25, 2017.
- F2Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F3100% of the restricted stock units vested on May 25, 2018. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.